![Sumit Aggarwal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sumit Aggarwal
Directeur Général chez
ELOXX PHARMACEUTICALS, INC.
Fortune : 248 920 $ au 31/05/2026
Profil
Sumit Aggarwal is currently President, Chief Executive Officer & Director at Eloxx Pharmaceuticals, Inc. since 2021.
Former roles include Chief Executive Officer at Endolytix Technology, Inc., Director at Neoseq Ltd. from 2016 to 2018, Analyst at Hartford Investment Management Co., Portfolio Manager at Adage Capital Management LP from 2007 to 2011, Associate Partner at McKinsey & Co., Inc. from 1998 to 2005, President & Chief Financial Officer at Biora Therapeutics, Inc. from 2015 to 2018, and Chief Financial & Business Officer at Zikani Therapeutics, Inc. from 2018 to 2019.
Education includes an MBA from Cornell University in 1998 and an undergraduate degree from Indian Institute of Technology Kharagpur in 1993.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/06/2026 | 672 756 ( 16,67% ) | 248 920 $ | 31/05/2026 |
Postes actifs de Sumit Aggarwal
| Sociétés | Poste | Début |
|---|---|---|
| ELOXX PHARMACEUTICALS, INC. | Directeur Général | 01/04/2021 |
Anciens postes connus de Sumit Aggarwal
| Sociétés | Poste | Fin |
|---|---|---|
| BIORA THERAPEUTICS, INC. | Directeur Financier/CFO | 01/01/2018 |
Neoseq Ltd.
 Neoseq Ltd. Medical/Nursing ServicesHealth Services Develops and provides healthcare solutions | Directeur/Membre du Conseil | 01/01/2018 |
Hartford Investment Management Co.
 Hartford Investment Management Co. Investment ManagersFinance HIMCO manages investment portfolios using a balanced top-down, bottom-up investment process, with multiple levels of investment input, within a governance framework that is designed to ensure thematic consistency. They offer a wide range of asset classes and manage fixed income and alternative investment strategies. The Investment Strategy Committee (ISC) has overall responsibility for all aspects of the investment process. | Analyst-Equity | 30/09/2008 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | 01/12/2005 |
Endolytix Technology, Inc.
 Endolytix Technology, Inc. Pharmaceuticals: MajorHealth Technology Develops enzyme-based therapeutics for intracellular mycobacterial infections | Directeur Général | - |
Formation de Sumit Aggarwal
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
100
+
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Hartford Investment Management Co.
Hartford Investment Management Co. Investment ManagersFinance HIMCO manages investment portfolios using a balanced top-down, bottom-up investment process, with multiple levels of investment input, within a governance framework that is designed to ensure thematic consistency. They offer a wide range of asset classes and manage fixed income and alternative investment strategies. The Investment Strategy Committee (ISC) has overall responsibility for all aspects of the investment process. | Finance |
Adage Capital Management LP
 Adage Capital Management LP Investment ManagersFinance Adage manages ACP primarily through industry-specific portfolios that are managed by analyst/portfolio manager teams or individuals. The ACP aims to provide investors with compound annual long-term returns that outperform the returns of the S&P 500 Index. Their analysts focus on adding value by stock selection based on intra-industry fundamental analysis. In addition to taking long positions, the firm uses leverage, sells securities short, and invests in derivatives, US and non-US equities and private securities. | Finance |
Zikani Therapeutics, Inc.
 Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Focuses on the discovery and development of novel macrolide antibiotics for the treatment of life-threatening bacterial infections caused by drug resistant pathogens | Retail Trade |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indian Institute of Technology Kharagpur
 Indian Institute of Technology Kharagpur Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biora Therapeutics, Inc.
 Biora Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing targeted therapies for cancer and autoimmune diseases | Health Technology |
Eloxx Pharmaceuticals, Inc.
 Eloxx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics to treat cystic fibrosis, inherited retinal disorders and other diseases | Health Technology |
Neoseq Ltd.
Neoseq Ltd. Medical/Nursing ServicesHealth Services Develops and provides healthcare solutions | Health Services |
Endolytix Technology, Inc.
Endolytix Technology, Inc. Pharmaceuticals: MajorHealth Technology Develops enzyme-based therapeutics for intracellular mycobacterial infections | Health Technology |
Choisissez Zonebourse 
